Reuters - Generic versions of expensive biotechnology drugs would reduce the amount of money spent on health care in the United States, a Federal Trade Commission report said on Thursday.
Original post by Reuters and software by Elliott Back
Continue reading about FTC: 12-14 yrs too long to protect biotech drugs (Reuters)
Recent Comments